Read + Share
Yadollahi P, McCord KA, Li Y, Dayoub H, et al. Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer
through effective PI3Kinase targeting. Br J Cancer 2025 Oct 6. doi: 10.1038/s41416-025-03189.
PMID: 41053162
|
 |
|
Yadollahi P, McCord KA, Li Y, Dayoub H, et al. Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer
through effective PI3Kinase targeting. Br J Cancer 2025 Oct 6. doi: 10.1038/s41416-025-03189.
PMID: 41053162
|
|
|
|